Skip to main content

Table 2 Data analysis for the human serum samples. The levels of BMI, glucose, insulin, HOMA value, Twist1, Twist2, and PPARγ were recorded. Statistical analysis was performed using ANOVA. P < 0.05 was considered to indicate a significant difference

From: TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis

Parameter BMI (X ± SD) glucose (mmol/L,X ± SD) insulin (mIU/L, X ± SD) HOMA (X ± SD) Twist1 concentration (pg/mL, X ± SD) Twist2 concentration (pg/mL, X ± SD) PPARγ concentration (mmol/L, X ± SD)
Group
healthy control 22.42 ± 2.54□, , ※ 4.98 ± 0.50□, , ※ 6.93 ± 3.12□, , ※ 1.54 ± 0.74□, , ※ 287.54 ± 264.02□, 2.63 ± 2.26 258.88 ± 241.26
mild fatty liver 26.32 ± 2.45, , ※ 5.35 ± 0.50, , ※ 9.19 ± 4.18, , ※ 2.19 ± 1.02, , ※ 176.62 ± 166.08, , ※ 2.00 ± 1.34 227.84 ± 208.65
moderate fatty liver 28.25 ± 2.75, □, ※ 5.92 ± 1.59, □, ※ 11.82 ± 6.77, □, ※ 3.15 ± 2.07, □, ※ 380.39 ± 331.48, □, ※ 2.04 ± 1.37 216.30 ± 177.04
severe fatty liver 31.30 ± 3.31, □, 6.29 ± 1.93, □, 15.29 ± 7.66, □, 4.20 ± 2.23, □, 279.26 ± 238.77□, 2.06 ± 1.16 225.72 ± 182.68
  1. BMI: body mass index, kg/m2, HOMA homeostasis model assessment; P < 0.05, compared with healthy controls; P < 0.05, compared with mild fatty liver; P < 0.05, compared with moderate fatty liver; P < 0.05, compared with severe fatty liver